(Q43542379)

24 November 2017

Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy (English)

1 reference

24 November 2017

1 reference

Merrick GS

1

1 reference

24 November 2017

Butler WM

2

1 reference

24 November 2017

Galbreath RW

3

1 reference

24 November 2017

Lief JH

4

1 reference

24 November 2017

Donzella JG

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

57

1 reference

24 November 2017

3

1 reference

24 November 2017

524-529

1 reference

Temporal resolution of urinary morbidity following prostate brachytherapy

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Short-term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Complications after prostate brachytherapy in the Medicare population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: correlation of resected weight, blood loss and duration of operation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Comparison of seed loading approaches in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Potential role of various dosimetric quality indicators in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Rectal dosimetric analysis following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901017-7

7 January 2021

10.1016/S0090-4295(00)01017-7

Identifiers

DOI

1 reference

24 November 2017

1 reference